Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Hall T Martin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hall T Martin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Startup Funding Espresso – Sales for a Biotherapeutic Startup

2:04
 
Share
 

Manage episode 515886704 series 2414821
Content provided by Hall T Martin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hall T Martin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Sales for a Biotherapeutic Startup

Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.

In a tech startup, the customer is the one who buys the product.

In a biotherapeutic startup, the customer is the pharma company that will buy the company.

While almost all tech startups launch a product and sell it to the user, the biotherapeutic startup rarely launches the startup to sell the product.

The cost to launch a biotherapeutic company is very high, given the cost of deploying the sales force and producing the product.

The biotherapeutic startup spends its time identifying the right pharma company.

This includes a review of their product line, intellectual property portfolio, and position in their sector.

The CEO of the biotherapeutic spends time with potential acquirers of the startup to learn more about their priorities.

The CEO looks for a candidate pharma company that does not already have the same IP as the startup.

Biotherapeutics, in most cases, are looking for IP that fills a gap in their patent portfolio.

In launching a biotherapeutic startup, identify the ideal customer profile and then match to the existing pharma companies on the market.

Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding. Let's go startup something today.

_________________________________________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org

Check out our other podcasts here: https://investorconnect.org/ For Investors check out: https://tencapital.group/investor-landing/ For Startups check out: https://tencapital.group/company-landing/ For eGuides check out: https://tencapital.group/education/ For upcoming Events, check out https://tencapital.group/events/

For Feedback please contact [email protected]

Please follow, share, and leave a review.

Music courtesy of Bensound.

  continue reading

2570 episodes

Artwork
iconShare
 
Manage episode 515886704 series 2414821
Content provided by Hall T Martin. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Hall T Martin or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Sales for a Biotherapeutic Startup

Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing.

In a tech startup, the customer is the one who buys the product.

In a biotherapeutic startup, the customer is the pharma company that will buy the company.

While almost all tech startups launch a product and sell it to the user, the biotherapeutic startup rarely launches the startup to sell the product.

The cost to launch a biotherapeutic company is very high, given the cost of deploying the sales force and producing the product.

The biotherapeutic startup spends its time identifying the right pharma company.

This includes a review of their product line, intellectual property portfolio, and position in their sector.

The CEO of the biotherapeutic spends time with potential acquirers of the startup to learn more about their priorities.

The CEO looks for a candidate pharma company that does not already have the same IP as the startup.

Biotherapeutics, in most cases, are looking for IP that fills a gap in their patent portfolio.

In launching a biotherapeutic startup, identify the ideal customer profile and then match to the existing pharma companies on the market.

Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding. Let's go startup something today.

_________________________________________________________

For more episodes from Investor Connect, please visit the site at: http://investorconnect.org

Check out our other podcasts here: https://investorconnect.org/ For Investors check out: https://tencapital.group/investor-landing/ For Startups check out: https://tencapital.group/company-landing/ For eGuides check out: https://tencapital.group/education/ For upcoming Events, check out https://tencapital.group/events/

For Feedback please contact [email protected]

Please follow, share, and leave a review.

Music courtesy of Bensound.

  continue reading

2570 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play